MARGetuximab Or Trastuzumab (MARGOT): A phase II study comparing neoadjuvant paclitaxel/margetuximab/pertuzumab to paclitaxel/trastuzumab/pertuzumab in patients with Stage II-III HER2-positive breast cancer
NOT ENROLLING
Trial ID:
NCT04425018 Protocol # :
20-068
Phase
II
Disease Sites
Breast
Principal Investigator
Waks, Adrienne
Site Research Nurses
Brule, Maurice, N.
Cronis, Charles, Lewis
Cung, Connie
Fleischmann-Rose, Kristin, Elizabeth
Gentile, Alissa
Ginter, Lindsey
Hixon, Nicole, R.
Houghton, Nicole
Jeon, Maryangel, H.
Katz, Rebecca Paolillo
Kosinski, Michelle
Kuhlman, Rachel
Miles, Brandy
Piper, Audrey, L.
Quinn, Caroline
Sheehan, Susan
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #20-068
20-068